Irbesartan-HCTZ recall in Canada: impurity risk
In plain language
This recall involves Irbesartan-HCTZ tablets sold in Canada. It's being recalled because an impurity was found above acceptable limits. Stop using the product and follow the return steps in the official notice.
What to do
- Stop using the product immediately.
- Check the lot numbers on your medication.
- Contact your pharmacist or doctor for advice on returning or disposing of the product.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Irbesartan-HCTZ (Hydrochlorothiazide 12.5mg / Irbesartan 300mg)
Lot: HW0586, HW0587
Why this matters
Presence of impurity
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: HW0586, HW0587
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Presence of impurity
What should consumers do?
Stop using the product immediately. Check the lot numbers on your medication. Contact your pharmacist or doctor for advice on returning or disposing of the product.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Presence of impurity
When was this product recalled?
This product was recalled on January 12, 2021.